PX-478 2HCl
目录号 : GC11031PX-478是一种选择性抑制剂,可以抑制常规和低氧诱导的HIF-1α水平。
Cas No.:685898-44-6
Sample solution is provided at 25 µL, 10mM.
PX-478 is a selective inhibitor that suppresses constitutive and hypoxia-induced HIF-1α levels. PX-478 inhibits HIF-1α at multiple levels including inhibition of HIF-1α translation and reduction in HIF-1α mRNA levels.[1] PX-478 also has been shown antitumor activity against several aggressive human tumor xenografts.[2]
In vitro and in vivo study demonstrated that PX-478 could inhibit normoxic and hypoxia-induced HIF-1α expression as well as inflammatory molecule COX-2 and immunosuppressive molecule PD-L1 expression. Therefore, PX-478 shows a wide effect on tumor development, such as suppressing proliferation, promoting cells apoptosis, inhibiting EMT process and arresting cell cycle. In vivo experiment indicated the inhibitory effect of PX-478 on tumor growth. [1]
References:
[1].Zhu Y, et al. Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo. Am J Cancer Res. 2017 May 1;7(5):1198-1212.
[2].Palayoor ST, et al. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. Int J Cancer. 2008 Nov 15;123(10):2430-7.
PX-478是一种选择性抑制剂,可以抑制常规和低氧诱导的HIF-1α水平。PX-478在多个层面上抑制HIF-1α,包括抑制HIF-1α翻译和降低HIF-1α mRNA水平。[1]此外,PX-478还显示出对几种侵袭性人类肿瘤异种移植的抗肿瘤活性。[2]
体外和体内研究表明,PX-478可以抑制正常氧和低氧诱导的HIF-1α表达以及炎性分子COX-2和免疫抑制分子PD-L1的表达。因此,PX-478对肿瘤发展具有广泛影响,如抑制增殖、促进细胞凋亡、抑制EMT过程并阻止细胞周期。体内实验显示了PX-478对肿瘤生长的抑制作用。[1]
Cell experiment [1]: | |
Cell lines |
EC109 and EC9706 cell lines |
Preparation Method |
Both cell lines were cultured in RPMI 1640 supplemented with 10% FBS at 37°C in a 5% CO2 humidified incubator. Cells were starved for 24 h in medium containing 0.1% FBS prior to treatment. |
Reaction Conditions |
PX-478 was added to the cultures to a final concentration of 20 umol/L after serum starvation overnight. |
Applications |
PX-478 could inhibit normoxic and hypoxia-induced HIF-1α expression as well as COX-2 and PD-L1 expression in vitro at a dose of 20 μM in EC9706 and EC109 cells. Targeted HIF-1α can effectively reduce their expression. |
Animal experiment [1]: | |
Animal models |
6-week-old female BALB/c nude mice, 18 ± 2 g, SPF grade |
Preparation Method |
EC109 cells were re-suspended in PBS at 107/mL. A total of 12 BABL/c nude female mice were used. Mice were injected with EC109 cells in the right flank area to establish the tumor xenograft. The 12 tumor-bearing mice in each group were randomly divided into the control group and the PX-478 groups. All the drugs were delivered via p.o. gavage administration. |
Dosage form |
30 mg/kg every other day |
Applications |
PX-478 shows a wide effect on tumor development, such as suppressing proliferation, promoting cells apoptosis, inhibiting EMT process and arresting cell cycle. In vivo mouse xenograft models showed the inhibitory effect on tumor growth. In addition, it can reduce COX-2 and PD-L1 expression. |
References: [1].Zhu Y, et al. Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo. Am J Cancer Res. 2017 May 1;7(5):1198-1212. |
Cas No. | 685898-44-6 | SDF | |
化学名 | (S)-4-(2-amino-2-carboxyethyl)-N,N-bis(2-chloroethyl)aniline oxide dihydrochloride | ||
Canonical SMILES | ClCC[N+](C1=CC=C(C[C@@](N)([H])C(O)=O)C=C1)([O-])CCCl.Cl.Cl | ||
分子式 | C13H20Cl4N2O3 | 分子量 | 394.12 |
溶解度 | 79mg/mL in DMSO (200.45mM), 79mg/mL in Water (200.45mM), 79mg/mL in Ethanol (200.45mM) | 储存条件 | Store at -20°C, stored under nitrogen, away from moisture |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.5373 mL | 12.6865 mL | 25.373 mL |
5 mM | 0.5075 mL | 2.5373 mL | 5.0746 mL |
10 mM | 0.2537 mL | 1.2686 mL | 2.5373 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
-
Related Biological Data
Effects of ononin combined with radiation on tumor growth and tumor cell apoptosis in human lung cancer subcutaneous tumor-bearing nude mice model. (D) Representative images of Hematoxylin-eosin (H&E) staining, Ki67 immunohistochemical staining (Scar bars = 40 µm) and TUNEL staining.
PX-478 was purchased from GLPBIO (GC11031, GLPBIO,Montclair, USA),(40mg/kg, 0.2ml, ip).
Phytomedicine 125 (2024): 155290. PMID: 38308918 IF: 7.8996 -
Related Biological Data
(c) Quantitative comparison of the number of CD31+ vessels between TCPS with PX-478 or PBS injection after implantation in FVB mice at 14 d per FOV.
The post-surgery mice were administered of PX478 (100mg kg -1)(GlpBio, USA) in phosphate buffer solution (PBS) every other day for a total of 2 weeks according to Agarwal’s protocol.
J Mater Chem B (2022). PMID: 35971918 IF: 7.5711 -
Related Biological Data
Inhibition of HIF-1α signaling alleviated FA-induced glycolysis in PMs. B, intracellular MGO levels was demonstrated by the mean fluorescence intensity of NAP-DCP-1.
RAW 264.7 cells were pretreated with 30μM PX-478(GlpBio, USA)(a specific HIF-1α inhibitor) for 24h to block HIF-1α signaling.
Chem-Biol Interact 379 (2023): 110514. PMID: 37105513 IF: 5.1 -
Related Biological Data
CM from FA-treated tumor cells and MGO promoted TAM polarization. B, % of M2 TAM measured by CD163+ CD206+ double positive population.
Hela cells were treated with 0, 20, 50μM FA or 50μM FA + 5μM PX-478 (HIF-1α inhibitor)(GlpBio, USA) for 24h.
Toxicol Appl Pharm (2022): 115910. PMID: 35134435 IF: 4.219